Developer docs
API playgroundTry for free, no card

Search company profiles

Mint Medical

Full company profile

uuid000jo52

Namestring
Mint Medical
Legal namestring
Mint Medical GmbH
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Mint Medical GmbH is a Heidelberg-based, private German software company founded in 2010 that develops mint Lesion, a regulated radiological software platform used for standardized and computer-assisted evaluation of imaging and clinical data. The platform provides AI-augmented guided structured reporting, dynamic implementation of oncology response criteria (RECIST, iRECIST, PI-RADS, PERCIST, BONE-RADS, Lung-RADS), and exports FHIR-compliant datasets with HIPAA and FDA CFR Part 11-capable audit trails. It is a Class II medical device (CE-marked since 2010, FDA 510(k)-cleared since 2011, certified to ISO 13485:2016 and EU MDR Annex IX) and serves diagnostic radiology departments in hospitals and university medical centers, pharmaceutical and contract research organizations running clinical trials, and academic imaging biomarker research groups. The portfolio includes the core mint Lesion platform, mint REX for radiology workflow, and mint Analytics for visual data analysis.

Mint Medical generates revenue primarily through enterprise licensing of mint Lesion (subscription or perpetual, quote-based) and complementary professional services including implementation, training, and customization billed on time-and-materials or fixed unit price terms. The go-to-market is enterprise field sales targeting large healthcare institutions and pharma/CRO clients through consultative demos, supplemented by presence at major radiology conferences (RSNA, ICIS, ESUR), direct website demo requests, and content marketing via LinkedIn, YouTube, and a Knowledge Hub. Customers include University Hospitals (Essen, Jena, Ulm, Cologne, Freiburg, Basel), Imperial College London, Sapienza University of Rome, Stanford, Royal Marsden NHS, and SLK Clinics Heilbronn. Following its March 2021 acquisition by Brainlab AG, Mint Medical became part of the Munich-based Snke healthcare technology ecosystem in June 2025 and has since pursued a platform strategy integrating third-party AI partners (Coreline Soft for lung cancer screening, ICR/Royal Marsden for bone disease AI), with a US office in Hamilton, NJ supporting North American sales.

Short descriptiontext

Mint Medical GmbH is a Heidelberg-based, private German software company that develops mint Lesion, a regulated (CE-marked, FDA 510(k)-cleared) radiological platform for AI-augmented structured reporting and clinical trial imaging. It serves university hospitals, pharma/CROs, and imaging biomarker researchers across EMEA and North America, and is part of the Snke ecosystem.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHeidelberg, Germany
HQ citystring
Heidelberg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
radiological reporting software, medical imaging analytics, clinical trial imaging, structured radiology reporting, imaging biomarker software
Industry2 codes
1AI/Analytics for RPM (Risk Stratification, Alerts, Predictive)
CodeHLACAFAMPrimaryYes
2Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management)
CodeHLALAFALPrimaryNo
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Imaging Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Software Licensing (mint Lesion)
TypeSubscription Recurring
Description

Mint Medical generates revenue through licensing of its mint Lesion software platform, which is sold as a configurable solution for diagnostic radiology, clinical trials, and imaging biomarker research. The software supports subscription or perpetual licensing models based on customer needs and deployment scope.

mint-medical.com
2Professional Services
TypeProfessional Services
Description

Services including implementation, training, and customization are invoiced on a time-and-materials basis or at fixed unit prices. Travel and other expenses are billed additionally.

mint-medical.com
3Project Services
TypeProfessional Services
Description

Project-based work services invoiced at unit prices or on time-and-materials basis after completion and acceptance of services.

mint-medical.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise licensing for large healthcare institutions and pharma/CRO clients
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing tailored to institutional needs, number of users, deployment scope, and feature requirements.

mint-medical.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1mint Lesion
Description

Radiological software solution for standardized and computer-assisted evaluation of radiological and clinical data, including AI-powered structured reporting, guided assessment, and data-driven analytics

mint-medical.com
+2 more records
Core offering1 text field

Mint Medical develops and licenses the mint Lesion software platform, an AI-augmented radiological image reading and reporting solution for diagnostic radiology, clinical trials, and imaging biomarker research. The platform provides guided structured reporting, automated response criteria compliance (e.g., RECIST, iRECIST, PI-RADS), longitudinal multi-site reading, and FHIR-compliant data export with HIPAA and FDA CFR Part 11-capable audit trails. Companion offerings mint REX and mint Analytics extend the platform with additional radiology workflow and visual analytics capabilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • mint Lesion generates machine-readable data in a semantic data model with HIPAA- and FDA CFR Part 11-capable audit trail for clinical trials phases I to III
+2 more records
Product overview1 text field

Mint Medical develops and markets the leading radiological software solution mint Lesion, a platform that provides AI-powered structured reporting, guided assessment, and data-driven analytics. The product portfolio consists of the core mint Lesion platform complemented by specialized modules for Clinical Routine (diagnostic radiology with TNM, PI-RADS, RECIST support), Clinical Trials (phases I-III with automated response criteria), Imaging Biomarker Research, and Pharma/CRO applications. mint Lesion is used worldwide by healthcare providers, academic medical centers, and clinical research organizations. The platform integrates AI including Deep Learning and knowledge-based models, supports ontologies like RadLex, SNOMED, and CDISC SDTM, and generates FHIR-compliant datasets with audit trails compliant with HIPAA and FDA CFR Part 11. The companion product mint REX provides additional radiological workflow capabilities, while mint Analytics adds visual data analysis including volumetrics and radiomics.

Product and service3 records
1mint Lesion
CategoryRadiological Image Reading and Reporting Software
Description

The core radiological software platform for standardized, computer-assisted evaluation of radiological and clinical data. mint Lesion provides AI-powered structured reporting, guided assessment, and data-driven analytics for diagnostic radiology, clinical trials, and imaging biomarker research. It supports TNM staging, PI-RADS, RECIST, iRECIST, PERCIST, BONE-RADS, Lung-RADS, and other standardized assessment criteria, with FHIR-compliant data export and HIPAA/FDA CFR Part 11-capable audit trails. Used by university hospitals, clinics, radiology practices, academic centers, and pharma/CROs.

2mint REX
CategoryRadiology Workflow Software
Description

Radiological software solution for structured reporting and workflow management in radiology departments, complementing the mint Lesion platform as an additional offering from Mint Medical.

3mint Analytics
CategoryRadiological Data Analytics Software
Description

Visual data analytics software integrated with mint Lesion, providing advanced analytics capabilities including volumetrics, radiomics feature extraction, and tumor growth rate analysis for longitudinal radiological research and clinical trial imaging data review.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-06-18
Description

Strategic partnership to integrate Coreline Soft's AVIEW AI imaging platform with Mint Medical's mint Lesion structured reporting system for AI-enabled lung cancer screening workflows. The integration supports pulmonary nodule detection, structured reporting, longitudinal tracking, and multi-site reading management. Initially focused on Germany following the April 2026 introduction of LDCT-based lung cancer screening into statutory health insurance reimbursement, with plans to scale across international markets.

Strategic tierCoreTypeOthersAnnounced on2025-06-01
Description

Since June 2025, Mint Medical is part of Snke, a healthcare technology ecosystem. Snke drives digital transformation of healthcare from Munich with innovative solutions based on AI, Big Data, and scalable technologies. Mint Medical maintains its headquarters in Heidelberg while benefiting from the Snke ecosystem for career opportunities and cross-company collaboration.

3The Institute of Cancer Research (ICR) and The Royal Marsden NHS Foundation Trust
Strategic tierCoreTypeTechnology or Integration
Description

Licensing agreement for integration of AI-powered software developed by ICR and The Royal Marsden into mint Lesion. The solution supports bone disease assessment and treatment response evaluation in advanced prostate cancer and multiple myeloma. The partnership represents Mint Medical's strategy to integrate validated clinical AI algorithms into its platform.

mint-medical.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Former parent company of Mint Medical and a major incumbent in surgery, radiotherapy, and imaging software. Overlapping customer base in hospitals and radiology, with broader portfolio of clinical software products.

TypeEmerging player
Description

Public medical imaging AI company focused on oncology detection and biomarker analysis. Competes with portions of mint Lesion's AI-augmented diagnostic offering, particularly in lung and breast imaging AI.

TypeBroad incumbent
Description

Global health technology incumbent with IntelliSpace radiology and clinical trial imaging offerings. Competes broadly in the same hospital and clinical research accounts mint Lesion serves.

TypeBroad incumbent
Description

Major imaging equipment and software incumbent with Edison AI platform and integrated radiology reporting. Comparable as a broad enterprise imaging IT vendor whose structured reporting and AI capabilities overlap with mint Lesion.

TypeDirect peer
Description

Provider of medical image analysis software for quantitative assessment in clinical trials and clinical routine. Comparable as a regulated imaging software vendor selling into academic medical centers, pharma, and CROs.

TypeDirect peer
Description

Public Swedish developer of treatment planning and oncology workflow software used in radiation therapy and radiology. Directly comparable to Mint Medical as a specialized, regulated software vendor serving oncology clinical workflows, university hospitals, and clinical trial imaging.

TypeBroad incumbent
Description

Global medical imaging and diagnostics major with AI-Rad Companion and integrated reading workflow offerings. Competes broadly with mint Lesion via bundled PACS, reporting, and AI features inside dominant enterprise imaging installs.

TypeDirect peer
Description

Medical imaging AI and radiomics platform targeting oncology and clinical research use cases. Competes with mint Lesion for biomarker research and pharma imaging budgets with a comparable AI-augmented, structured-data proposition.

TypeDirect peer
Description

Imaging biomarker and clinical trial imaging software vendor focused on oncology. Closely comparable to mint Lesion's clinical trial imaging offering, serving pharma and CRO clients with standardized, regulatory-grade imaging endpoints.

TypeBroad incumbent
Description

Large global CRO with a dedicated Medical Imaging division offering centralized imaging review and analysis for clinical trials. Comparable as a scaled, broad-spectrum provider of imaging services and software to pharma sponsors.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mint Medical

Medical Imaging Softwaremint-medical.com

Mint Medical GmbH is a Heidelberg-based, private German software company that develops mint Lesion, a regulated (CE-marked, FDA 510(k)-cleared) radiological platform for AI-augmented structured reporting and clinical trial imaging. It serves university hospitals, pharma/CROs, and imaging biomarker researchers across EMEA and North America, and is part of the Snke ecosystem.

What Mint Medical does

Mint Medical GmbH is a Heidelberg-based, private German software company founded in 2010 that develops mint Lesion, a regulated radiological software platform used for standardized and computer-assisted evaluation of imaging and clinical data. The platform provides AI-augmented guided structured reporting, dynamic implementation of oncology response criteria (RECIST, iRECIST, PI-RADS, PERCIST, BONE-RADS, Lung-RADS), and exports FHIR-compliant datasets with HIPAA and FDA CFR Part 11-capable audit trails. It is a Class II medical device (CE-marked since 2010, FDA 510(k)-cleared since 2011, certified to ISO 13485:2016 and EU MDR Annex IX) and serves diagnostic radiology departments in hospitals and university medical centers, pharmaceutical and contract research organizations running clinical trials, and academic imaging biomarker research groups. The portfolio includes the core mint Lesion platform, mint REX for radiology workflow, and mint Analytics for visual data analysis.

Mint Medical generates revenue primarily through enterprise licensing of mint Lesion (subscription or perpetual, quote-based) and complementary professional services including implementation, training, and customization billed on time-and-materials or fixed unit price terms. The go-to-market is enterprise field sales targeting large healthcare institutions and pharma/CRO clients through consultative demos, supplemented by presence at major radiology conferences (RSNA, ICIS, ESUR), direct website demo requests, and content marketing via LinkedIn, YouTube, and a Knowledge Hub. Customers include University Hospitals (Essen, Jena, Ulm, Cologne, Freiburg, Basel), Imperial College London, Sapienza University of Rome, Stanford, Royal Marsden NHS, and SLK Clinics Heilbronn. Following its March 2021 acquisition by Brainlab AG, Mint Medical became part of the Munich-based Snke healthcare technology ecosystem in June 2025 and has since pursued a platform strategy integrating third-party AI partners (Coreline Soft for lung cancer screening, ICR/Royal Marsden for bone disease AI), with a US office in Hamilton, NJ supporting North American sales.

Mint Medical firmographics

Firmographics
Name
Mint Medical
Legal name
Mint Medical GmbH
Website
https://mint-medical.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
Mint Medical GmbH is a Heidelberg-based, private German software company that develops mint Lesion, a regulated (CE-marked, FDA 510(k)-cleared) radiological platform for AI-augmented structured reporting and clinical trial imaging. It serves university hospitals, pharma/CROs, and imaging biomarker researchers across EMEA and North America, and is part of the Snke ecosystem.
Ownership category
akta.pro rank

Mint Medical industry classification

Industry
Product category
Medical Imaging Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
AI/Analytics for RPM (Risk Stratification, Alerts, Predictive) (HLACAFAM)
akta.pro secondary industry
Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management) (HLALAFAL)

Keywords

  • Radiological reporting software
  • Medical imaging analytics
  • Clinical trial imaging
  • Structured radiology reporting
  • Imaging biomarker software

Where Mint Medical is headquartered

Location

Headquarters

HQ city
Heidelberg
HQ country
Germany
HQ region
Europe

Offices3 records

Markets served

Mint Medical business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Software Licensing (mint Lesion): Mint Medical generates revenue through licensing of its mint Lesion software platform, which is sold as a configurable solution for diagnostic radiology, clinical trials, and imaging biomarker research. The software supports subscription or perpetual licensing models based on customer needs and deployment scope.
  2. Professional Services: Services including implementation, training, and customization are invoiced on a time-and-materials basis or at fixed unit prices. Travel and other expenses are billed additionally.
  3. Project Services: Project-based work services invoiced at unit prices or on time-and-materials basis after completion and acceptance of services.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise licensing for large healthcare institutions and pharma/CRO clients

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Mint Medical product offering

Product offering

Core offering

Mint Medical develops and licenses the mint Lesion software platform, an AI-augmented radiological image reading and reporting solution for diagnostic radiology, clinical trials, and imaging biomarker research. The platform provides guided structured reporting, automated response criteria compliance (e.g., RECIST, iRECIST, PI-RADS), longitudinal multi-site reading, and FHIR-compliant data export with HIPAA and FDA CFR Part 11-capable audit trails. Companion offerings mint REX and mint Analytics extend the platform with additional radiology workflow and visual analytics capabilities.

Product overview

Mint Medical develops and markets the leading radiological software solution mint Lesion, a platform that provides AI-powered structured reporting, guided assessment, and data-driven analytics. The product portfolio consists of the core mint Lesion platform complemented by specialized modules for Clinical Routine (diagnostic radiology with TNM, PI-RADS, RECIST support), Clinical Trials (phases I-III with automated response criteria), Imaging Biomarker Research, and Pharma/CRO applications. mint Lesion is used worldwide by healthcare providers, academic medical centers, and clinical research organizations. The platform integrates AI including Deep Learning and knowledge-based models, supports ontologies like RadLex, SNOMED, and CDISC SDTM, and generates FHIR-compliant datasets with audit trails compliant with HIPAA and FDA CFR Part 11. The companion product mint REX provides additional radiological workflow capabilities, while mint Analytics adds visual data analysis including volumetrics and radiomics.

Differentiator

Problem solved

Functional benefit

Brands

  • mint Lesion: Radiological software solution for standardized and computer-assisted evaluation of radiological and clinical data, including AI-powered structured reporting, guided assessment, and data-driven analytics
  • mint REX
  • mint Analytics

Products and services

  • mint Lesion The core radiological software platform for standardized, computer-assisted evaluation of radiological and clinical data. mint Lesion provides AI-powered structured reporting, guided assessment, and data-driven analytics for diagnostic radiology, clinical trials, and imaging biomarker research. It supports TNM staging, PI-RADS, RECIST, iRECIST, PERCIST, BONE-RADS, Lung-RADS, and other standardized assessment criteria, with FHIR-compliant data export and HIPAA/FDA CFR Part 11-capable audit trails. Used by university hospitals, clinics, radiology practices, academic centers, and pharma/CROs.
  • mint REX Radiological software solution for structured reporting and workflow management in radiology departments, complementing the mint Lesion platform as an additional offering from Mint Medical.
  • mint Analytics Visual data analytics software integrated with mint Lesion, providing advanced analytics capabilities including volumetrics, radiomics feature extraction, and tumor growth rate analysis for longitudinal radiological research and clinical trial imaging data review.

Quantifiable outcome

  • mint Lesion generates machine-readable data in a semantic data model with HIPAA- and FDA CFR Part 11-capable audit trail for clinical trials phases I to III
  • +2 more outcomes

Companies that use Mint Medical

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Mint Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability6 records

Feature6 records

Mint Medical partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Coreline SoftcoreTechnology or Integration · 18 June 2026Strategic partnership to integrate Coreline Soft's AVIEW AI imaging platform with Mint Medical's mint Lesion structured reporting system for AI-enabled lung cancer screening workflows. The integration supports pulmonary nodule detection, structured reporting, longitudinal tracking, and multi-site reading management. Initially focused on Germany following the April 2026 introduction of LDCT-based lung cancer screening into statutory health insurance reimbursement, with plans to scale across international markets.
  • SnkecoreOthers · 1 June 2025Since June 2025, Mint Medical is part of Snke, a healthcare technology ecosystem. Snke drives digital transformation of healthcare from Munich with innovative solutions based on AI, Big Data, and scalable technologies. Mint Medical maintains its headquarters in Heidelberg while benefiting from the Snke ecosystem for career opportunities and cross-company collaboration.
  • The Institute of Cancer Research (ICR) and The Royal Marsden NHS Foundation TrustcoreTechnology or IntegrationLicensing agreement for integration of AI-powered software developed by ICR and The Royal Marsden into mint Lesion. The solution supports bone disease assessment and treatment response evaluation in advanced prostate cancer and multiple myeloma. The partnership represents Mint Medical's strategy to integrate validated clinical AI algorithms into its platform.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Mint Medical competitors and assessment

Company assessment

Broad incumbents

  • Brainlab: Former parent company of Mint Medical and a major incumbent in surgery, radiotherapy, and imaging software. Overlapping customer base in hospitals and radiology, with broader portfolio of clinical software products.
  • Philips (IntelliSpace): Global health technology incumbent with IntelliSpace radiology and clinical trial imaging offerings. Competes broadly in the same hospital and clinical research accounts mint Lesion serves.
  • GE HealthCare: Major imaging equipment and software incumbent with Edison AI platform and integrated radiology reporting. Comparable as a broad enterprise imaging IT vendor whose structured reporting and AI capabilities overlap with mint Lesion.
  • Siemens Healthineers (AI-Rad Companion): Global medical imaging and diagnostics major with AI-Rad Companion and integrated reading workflow offerings. Competes broadly with mint Lesion via bundled PACS, reporting, and AI features inside dominant enterprise imaging installs.
  • ICON plc (Medical Imaging): Large global CRO with a dedicated Medical Imaging division offering centralized imaging review and analysis for clinical trials. Comparable as a scaled, broad-spectrum provider of imaging services and software to pharma sponsors.

Emerging players

  • Lunit: Public medical imaging AI company focused on oncology detection and biomarker analysis. Competes with portions of mint Lesion's AI-augmented diagnostic offering, particularly in lung and breast imaging AI.

Direct peers

  • Perspectum: Provider of medical image analysis software for quantitative assessment in clinical trials and clinical routine. Comparable as a regulated imaging software vendor selling into academic medical centers, pharma, and CROs.
  • RaySearch Laboratories: Public Swedish developer of treatment planning and oncology workflow software used in radiation therapy and radiology. Directly comparable to Mint Medical as a specialized, regulated software vendor serving oncology clinical workflows, university hospitals, and clinical trial imaging.
  • Quibim: Medical imaging AI and radiomics platform targeting oncology and clinical research use cases. Competes with mint Lesion for biomarker research and pharma imaging budgets with a comparable AI-augmented, structured-data proposition.
  • Median Technologies: Imaging biomarker and clinical trial imaging software vendor focused on oncology. Closely comparable to mint Lesion's clinical trial imaging offering, serving pharma and CRO clients with standardized, regulatory-grade imaging endpoints.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Mint Medical social profiles

Digital presence

Mint Medical compliance and trust

Trust signal

Compliance4 records

Mint Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mint Medical leadership team

Management profile

Number of profiles

Profiles7 records

Mint Medical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mint Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mint Medical

What does Mint Medical do?

Mint Medical develops and licenses the mint Lesion software platform, an AI-augmented radiological image reading and reporting solution for diagnostic radiology, clinical trials, and imaging biomarker research. The platform provides guided structured reporting, automated response criteria compliance (e.g., RECIST, iRECIST, PI-RADS), longitudinal multi-site reading, and FHIR-compliant data export with HIPAA and FDA CFR Part 11-capable audit trails. Companion offerings mint REX and mint Analytics extend the platform with additional radiology workflow and visual analytics capabilities.

Is Mint Medical a public or private company?

Mint Medical is a private company. It is classified as corporate owned and is currently operating.

When was Mint Medical founded?

Mint Medical was founded in 2010. It employs 11 to 50 people.

Where is Mint Medical based?

Mint Medical is headquartered in Heidelberg, Germany, in the Europe region.

How does Mint Medical make money?

Three revenue lines are on record. Software Licensing (mint Lesion) is the primary driver. The others are professional Services and project Services.

Who are Mint Medical's main competitors?

Broad incumbents on record are Brainlab, Philips (IntelliSpace), GE HealthCare, Siemens Healthineers (AI-Rad Companion) and ICON plc (Medical Imaging). Lunit is listed as an emerging player. Direct peers are Perspectum, RaySearch Laboratories, Quibim and Median Technologies.

Does Mint Medical have an API?

No public API is recorded for Mint Medical.

What industry is Mint Medical in?

Mint Medical's product category is Medical Imaging Software. Its primary akta.pro industry code is HLACAFAM, AI/Analytics for RPM (Risk Stratification, Alerts, Predictive), with a secondary code of HLALAFAL, Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AuntMinnieEuropeCoreline Soft, Mint Medical partner on AI-enabled lung cancer screeningSouth Korea-based Coreline Soft and Mint Medical have announced a partnership to integrate AI-enabled lung cancer screening workflows, combining Coreline's AVIEW imaging platform with Mint's structured reporting system. The integration supports end-to-end screening including pulmonary nodule detection, structured reporting, longitudinal tracking, and multisite reading management. The partnership is initially focused on Germany, where low-dose CT lung cancer screening entered statutory health insurance reimbursement in April 2026, with plans to scale across international markets.TradingViewCoreline Soft and Mint Medical Announce Partnership to Advance AI-Enabled Lung Cancer ScreeningCoreline Soft and Mint Medical announced a partnership to integrate Coreline Soft's AI imaging platform AVIEW into Mint Medical's mint Lesion platform for AI-enabled lung cancer screening workflows. The integration supports pulmonary nodule detection, structured reporting, longitudinal tracking, and multi-site reading management, initially focused on Germany where LDCT-based lung cancer screening entered statutory health insurance reimbursement in April 2026. Coreline Soft's AVIEW has been applied in over 2.5 million clinical reads across hospitals in 19 countries, including major screening initiatives in Germany, France, and Italy.PR NewswireCoreline Soft and Mint Medical Announce Partnership to Advance AI-Enabled Lung Cancer ScreeningCoreline Soft and Mint Medical announced a partnership to integrate AI-enabled lung cancer screening technology, combining Coreline Soft's AVIEW imaging platform with Mint Medical's mint Lesion structured reporting platform following six months of technical collaboration. The collaboration is initially focused on Germany, where LDCT-based lung cancer screening entered statutory health insurance reimbursement in April 2026, with the integrated workflow designed to meet Germany's national screening requirements including double reading, CAD software utilization, longitudinal follow-up, and GDPR-compliant multi-site data management. The partnership is structured to scale across international markets where structured and operationally rigorous screening programs are emerging.